Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy And Safety Of Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Squamous Cell Carcinoma After Neoadjuvant Chemotherapy and Immunotherapy

NCT07780877 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07780877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07780877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy And Safety Of Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Squamous Cell Carcinoma After Neoadjuvant Chemotherapy and Immunotherapy
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2030
Enrollment
85 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

head & neck squamous cell carcinoma, locally advanced head and neck squamous cell carcinoma